%PDF-1.5
%
1 0 obj
<>stream
application/pdf
Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo‐controlled trial
Adobe LiveCycle PDFG ES; modified using iText 4.2.0 by 1T3XT
10.1002/hed.23655
10.1002/(ISSN)1097-0347
3
2015-05-15T12:30:22+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2021-05-10T23:47:52-07:00
2021-05-10T23:47:52-07:00
uuid:1cb0eb26-0f21-2db0-73fa-ca5c66bc38b4
uuid:011ff7d2-e34e-2ac7-521e-ca5c66bc38b4
endstream
endobj
7 0 obj
<>stream
Adobe d C
$$''$$53335;;;;;;;;;; 6"
3 !1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw ? ?!Ƴ]ʱnh5맏'_=s:@niOk[oV?מwtz=.̐܀MD8on6[M=39O NQc̀\h;>kG3,Ǽml5Ƽ'bծ]8c&̌325nHyԺf^/ށauw
mi ?W s-~=xXwKҎ8W:XOSfe.ݭkK0$Ui핗Z!GJë籌9 Ip'sYei퍟LI$I$I$I$I$I$I$I$I$I$I$I$I$I$I$W:S_0iʴ
q |Sa}ZwѠnѺWVcԱ*mGubևm'Th=r1h܆zw=2#i&